Drug companies, says Boucher, have little prospect of profiting off a drug that isn't likely to be taken by millions of people or fetch prices of tens of thousands of dollars per dose.

鲍彻说，制药公司很难从一种不太可能被数百万人服用或每剂售价数万美元的药物中获利。